within Pharmacolibrary.Drugs.ATC.J;

model J05AR20
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.93,
    Cl             = 7.17 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 200 / 1000000,
    adminCount     = 1,
    Vd             = 0.086,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.02,
    Tlag           = 10.200000000000001
  );

  annotation(Documentation(
    info ="<html><body><p>Emtricitabine, tenofovir alafenamide, and bictegravir is a fixed-dose combination antiretroviral medication used in the treatment of HIV-1 infection in adults and pediatric patients. It acts by inhibiting viral reverse transcriptase (emtricitabine, tenofovir) and integrase (bictegravir), preventing the replication of HIV-1. The combination is approved and widely used today.</p><h4>Pharmacokinetics</h4><p>Mean pharmacokinetic parameters reported for healthy HIV-negative adult subjects receiving the fixed-dose combination as a single oral tablet once daily under fasting conditions.</p><h4>References</h4><ol><li><p>Bruzzesi, E, et al., &amp; Castagna, A (2024). Pharmacokinetic evaluation of bictegravir + emtricitabine + tenofovir alafenamide in HIV treatment. <i>Expert opinion on drug metabolism &amp; toxicology</i> None 1–8. DOI:<a href=&quot;https://doi.org/10.1080/17425255.2024.2428820&quot;>10.1080/17425255.2024.2428820</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/39530796/&quot;>https://pubmed.ncbi.nlm.nih.gov/39530796</a></p></li><li><p>Lacombe-Duncan, A, et al., &amp; Loutfy, M (2024). Protocol of a drug-drug interaction study between bictegravir/emtricitabine/tenofovir alafenamide and feminizing hormones in trans women living with HIV. <i>British journal of clinical pharmacology</i> 90(10) 2349–2359. DOI:<a href=&quot;https://doi.org/10.1111/bcp.16162&quot;>10.1111/bcp.16162</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/38992893/&quot;>https://pubmed.ncbi.nlm.nih.gov/38992893</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end J05AR20;
